These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7933785)

  • 21. A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks.
    Orefice G; Carrieri P; Indaco A; Iorillo L; Fioretti A
    Acta Neurol (Napoli); 1984 Apr; 6(2):97-103. PubMed ID: 6204513
    [No Abstract]   [Full Text] [Related]  

  • 22. Left ventricular thrombi: changes in size and in platelet deposition during treatment with indobufen and ticlopidine.
    Bellotti P; Claudiani F; Chiarella F; Domenicucci S; Scopinaro G; Mazzotta G; Lupi G; Strada P; Vecchio C
    Cardiology; 1990; 77(4):272-9. PubMed ID: 2073644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.
    Rebuzzi AG; Natale A; Bianchi C; Mariello F; Coppola E; Ciabattoni G
    Eur J Clin Pharmacol; 1990; 39(1):99-100. PubMed ID: 2276396
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study.
    Pratesi C; Pulli R; Milanesi G; Lavezzari M; Pamparana F; Bertini D
    J Int Med Res; 1991; 19(3):202-9. PubMed ID: 1936509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The (+)-enantiomer is responsible for the antiplatelet and anti-inflammatory activity of (+/-)-indobufen.
    Cerletti C; Manarini S; Colombo M; Tavani A
    J Pharm Pharmacol; 1990 Dec; 42(12):885-7. PubMed ID: 1983157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
    Gürsoy AZ; Yardimci TU; Emekli NB; Ugur MS; Ulutin ON
    Haematologica; 1981 Dec; 66(6):756-67. PubMed ID: 6802717
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets.
    Dmoszyńska A; Walter-Croneck A; Ledwozyw A
    Thromb Res; 1995 Sep; 79(5-6):483-90. PubMed ID: 7502274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory activity of indobufen (*) on platelet aggregation in vivo.
    Bergamaschi M; Pierucci L; Branzoli U
    Pharmacol Res Commun; 1984 Oct; 16(10):979-85. PubMed ID: 6438651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution].
    Borghi B; Bugamelli S; deSimone N; Montebugnoli M; Ferrari S
    Minerva Anestesiol; 1990 Oct; 56(10):1117-20. PubMed ID: 2290518
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
    Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E
    Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
    Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C
    Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
    Vlasova II; Torkhovskaia TI; Fortinskaia ES; Khalilov EM; Azizova OA
    Biull Eksp Biol Med; 1996 Feb; 121(2):199-203. PubMed ID: 9026131
    [No Abstract]   [Full Text] [Related]  

  • 34. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.
    Fornaro G; Rossi P; Mantica PG; Caccia ME; Aralda D; Lavezzari M; Pamparana F; Milanesi G
    Circulation; 1993 Jan; 87(1):162-4. PubMed ID: 8419003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920).
    Pogliani E; Corvi G; Mandelli V; Fuccella LM
    Haematologica; 1981 Apr; 66(2):160-70. PubMed ID: 6115794
    [No Abstract]   [Full Text] [Related]  

  • 37. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of in vivo platelet aggregation by indobufen in angina patients during exercise.
    Pogliani EM; Fantasia R; Perini C; Corvi G
    J Int Med Res; 1981; 9(2):113-9. PubMed ID: 7014283
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic treatment of vascular diseases with indobufen].
    Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
    Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.